CAS No. 868540-17-4
| IUPAC Name | (2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide | |
|---|---|---|
| CAS Number | 868540-17-4 | |
| Molecular Formula |
C40H57N5O7 |
|
| Molecular Weight (MW) | 719.91 | |
| SMILES | CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4 | |
| InChIKey | BLMPQMFVWMYDKT-NZTKNTHTSA-N |
Carfilzomib (PR-171) is an irreversible proteasome inhibitor that selectively targets the chymotrypsin-like activity of the 20S proteasome. By blockading the ubiquitin-proteasome pathway, it causes accumulation of polyubiquitinated proteins, inducing endoplasmic reticulum stress and activating the apoptotic signaling cascade. This leads to potent growth inhibition and apoptosis in hematologic cell lines, particularly multiple myeloma cells, as well as autophagy disruption. [1][2]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(138.9 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 50 mg/mL |
| Water | Insoluble |
| DMSO |
100 mg/mL
(138.9 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 50 mg/mL |
| Water | Insoluble |
| DMSO |
100 mg/mL
(138.9 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
100 mg/mL
(138.9 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
100 mg/mL
(138.9 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- PR-171 (Carfilzomib) Mechanism of Action: Proteasome Inhibition in Plasma Cell Research
- PR-171 (Carfilzomib) Clinical Trials
- PR-171 (Carfilzomib): Selectivity & Specificity
- PR-171 (Carfilzomib) Working Concentration | Cell Culture | Treatment
- PR-171 (Carfilzomib) Solubility in DMSO
- PR-171 (Carfilzomib) Stock Solution
- PR-171 (Carfilzomib) Storage
- PR-171 (Carfilzomib) Stability
- PR-171 (Carfilzomib) Combination Database
- PR-171 (Carfilzomib) Molecular Weight
- PR-171 (Carfilzomib) SMILES
- PR-171 (Carfilzomib) Chemical Structure (2D and 3D)
- PR-171 (Carfilzomib) IC50 for Cell-based and Cell-free Assays
- PR-171 (Carfilzomib) Sigma (ADV412110416)? Try a better option.
- PR-171 (Carfilzomib) MedChemExpress (HY-10455)? Try a better option.
- PR-171 (Carfilzomib) Cayman (17554)? Try a better option.
- PR-171 (Carfilzomib) APExBIO (A1933)? Try a better option.
- PR-171 (Carfilzomib) Tocris (7188)? Try a better option.
- PR-171 (Carfilzomib) SDS|MSDS